Harpoon Therapeutics Inc. (HARP)
NASDAQ: HARP
· Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM
Harpoon Therapeutics Revenue Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration And License Revenue | 4.45M | 20.22M | 8.58M | 4.09M | 13.62M | 8.3M | 5.91M | 14.65M | 4.48M | 5.84M | 9.01M | 7.49M | 3.89M | 2.76M | 3.3M | 2.23M | 1.42M | 1.06M | 1.06M |
| Collaboration And License Revenue Growth | -78.00% | +135.59% | +109.90% | -69.97% | +64.00% | +40.59% | -59.68% | +226.65% | -23.19% | -35.18% | +20.22% | +92.45% | +40.95% | -16.23% | +47.58% | +57.66% | +33.30% | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.26M | 3.8M | 4.18M | 3.85M | 4.53M | 5.06M | 5.4M | 5.2M | 4.19M | 4.33M | 4.6M | 3.92M | 4.43M | 3.94M | 3.91M | 4.33M | 8.49M | 3.73M | 5.83M | 2.21M | 1.94M | 967K | 982K | 912K |
| Selling, General, and Administrative Revenue Growth | +12.07% | -9.13% | +8.59% | -14.90% | -10.55% | -6.26% | +3.83% | +24.27% | -3.44% | -5.84% | +17.33% | -11.38% | +12.24% | +0.82% | -9.69% | -48.98% | +127.45% | -35.97% | +163.30% | +14.06% | +100.83% | -1.53% | +7.68% | n/a |
| Research and Development Revenue | 12.32M | 12.2M | 15.16M | 18.95M | 20.98M | 20.65M | 20.82M | 20.66M | 16.97M | 18.27M | 16.22M | 15.06M | 13.06M | 11.92M | 12.52M | 12.71M | 9.53M | 9.97M | 9.38M | 8.72M | 5.97M | 6.15M | 5.53M | 4.79M |
| Research and Development Revenue Growth | +1.06% | -19.57% | -19.97% | -9.68% | +1.58% | -0.80% | +0.75% | +21.75% | -7.10% | +12.67% | +7.64% | +15.38% | +9.50% | -4.75% | -1.47% | +33.28% | -4.39% | +6.28% | +7.63% | +46.09% | -2.99% | +11.17% | +15.51% | n/a |